Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche.


Journal article


Paul J. Bröckelmann, Sven Borchmann, Peter Borchmann, Andreas Engert
Journal of Clinical Oncology, 2020 Aug 18

Cite

APA
Bröckelmann, P. J., Borchmann, S., Borchmann, P., & Engert, A. (2020). Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche. Journal of Clinical Oncology.

Chicago/Turabian
Bröckelmann, Paul J., Sven Borchmann, Peter Borchmann, and Andreas Engert. “Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche.” Journal of Clinical Oncology (August 18, 2020).

MLA
Bröckelmann, Paul J., et al. “Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche.” Journal of Clinical Oncology, Aug. 2020.